uniQure BV is looking for acquisition opportunities. It intends to use net proceeds from initial public offering and along with cash on hand to advance the development of our other product candidates, for working capital and for general corporate purposes, including service on our indebtedness and possibly acquisitions or investments in other businesses, technologies or product candidates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 USD | -8.03% | -16.30% | +25.11% |
09/07 | UniQure Huntington's Drug Candidate Slows Disease Progression in Updated Trials -- Shares Rise Pre-Bell | MT |
09/07 | Transcript : UniQure N.V. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.11% | 411M | |
+20.03% | 126B | |
+23.61% | 117B | |
+23.26% | 27.52B | |
-18.07% | 20.87B | |
-15.13% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- UniQure Seeks Acquisitions